Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia
- PMID: 21885611
- DOI: 10.1182/blood-2011-05-355206
Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia
Similar articles
-
Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.Mol Genet Genomic Med. 2021 Jul;9(7):e1700. doi: 10.1002/mgg3.1700. Epub 2021 May 27. Mol Genet Genomic Med. 2021. PMID: 34042331 Free PMC article.
-
A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.Blood. 2008 May 1;111(9):4496-9. doi: 10.1182/blood-2007-11-123885. Epub 2008 Feb 19. Blood. 2008. PMID: 18285546 Free PMC article.
-
Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.PLoS One. 2019 May 6;14(5):e0216328. doi: 10.1371/journal.pone.0216328. eCollection 2019. PLoS One. 2019. PMID: 31059548 Free PMC article.
-
L-asparaginase: an effective agent in the treatment of acute lymphoblastic leukemia.Leuk Lymphoma. 2014 Feb;55(2):256-62. doi: 10.3109/10428194.2013.803224. Epub 2013 Jun 14. Leuk Lymphoma. 2014. PMID: 23662993 Review.
-
Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B.Hematol Oncol Clin North Am. 2000 Dec;14(6):1367-79, x. doi: 10.1016/s0889-8588(05)70191-x. Hematol Oncol Clin North Am. 2000. PMID: 11147228 Review.
Cited by
-
Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study.J Clin Med. 2022 Apr 28;11(9):2489. doi: 10.3390/jcm11092489. J Clin Med. 2022. PMID: 35566613 Free PMC article.
-
Association between genetic polymorphisms and osteonecrosis in steroid treatment populations: a detailed stratified and dose-response meta-analysis.Biosci Rep. 2019 May 14;39(5):BSR20190024. doi: 10.1042/BSR20190024. Print 2019 May 31. Biosci Rep. 2019. PMID: 30996113 Free PMC article.
-
Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.Mol Genet Genomic Med. 2021 Jul;9(7):e1700. doi: 10.1002/mgg3.1700. Epub 2021 May 27. Mol Genet Genomic Med. 2021. PMID: 34042331 Free PMC article.
-
Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.Curr Hematol Malig Rep. 2017 Jun;12(3):176-186. doi: 10.1007/s11899-017-0376-z. Curr Hematol Malig Rep. 2017. PMID: 28317081 Review.
-
Inherited genetic variation in childhood acute lymphoblastic leukemia.Blood. 2015 Jun 25;125(26):3988-95. doi: 10.1182/blood-2014-12-580001. Epub 2015 May 21. Blood. 2015. PMID: 25999454 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous